Donkor, Isaac O Jones, Susan K Tidwell, Richard R
Published in
Bioorganic & medicinal chemistry letters
Butamidine analogues possessing unsaturation in the ether bridge between the bisamidinophenyl or bisimidazolinophenyl functionalities have been synthesized as semirigid congeners of pentamidine. These compounds demonstrated good anti-P. carinii pueumonia activity in a rat model of the disease.
Ha, Seung B Melman, Neli Jacobson, Kenneth A Nair, Vasu
Published in
Bioorganic & medicinal chemistry letters
N6-Substituted adenosine analogues containing cyclic hydrazines or chiral hydroxy (ar)alkyl groups, designed to interact with the S2 and S3 receptor subregions, have been synthesized and their binding to the adenosine A1 and A2A receptors have been investigated. Examples of both types of compounds were found to exhibit highly selective binding (Ki ...
Burkhart, J P Mehdi, S Koehl, J R Angelastro, M R Bey, P Peet, N P
Published in
Bioorganic & medicinal chemistry letters
Enol acetates of a-keto esters with E configuration were prepared as potential prodrugs for human neutrophil elastase (HNE) inhibitors.
Bailey, S Bolognese, B Buckle, D R Faller, A Jackson, S Louis-Flamberg, P McCord, M Mayer, R J Marshall, L A Smith, D G
...
Published in
Bioorganic & medicinal chemistry letters
A series of hydroxamic acids related to the non-selective matrix metalloprotease inhibitor Batimastat is described, which inhibits the proteolytic cleavage of the low affinity IgE receptor from cell membrane preparations. Limited SAR studies suggest that the structural requirements for effective inhibition are distinct from those required for the i...
Weinder-Wells, M A Altom, J Fernandez, J Fraga-Spano, S A Hilliard, J Ohemeng, K Barrett, J F
Published in
Bioorganic & medicinal chemistry letters
Ellagic acid was found to inhibit E. coli DNA gyrase supercoiling with approximately the same potency as nalidixic acid. Tricyclic analogs of ellagic acid, which vary in the number and position of the hydroxy groups as well as their replacement with halogens, have been synthesized. The biological activity of these analogs is discussed.
Auberson, Y P Acklin, P Allgeier, H Biollaz, M Bischoff, S Ofner, S Veenstra, S J
Published in
Bioorganic & medicinal chemistry letters
Potent antagonists at the glycine-binding site of NMDA receptors, as well as dual antagonists acting also at AMPA receptors have been identified in a series of 5-arylaminomethylquinoxaline-2,3-diones. A study of the structure-activity relationship of these compounds is reported here.
Cho, W J Park, M J Chung, B H Lee, C O
Published in
Bioorganic & medicinal chemistry letters
To investigate the structure-activity relationship of 7,8-dimethoxy-2- methyl-3-(4,5-methylenedioxy-2-vinylphenyl)isoquinolin-1(2H) -one 2, diverse substituted 3-arylisoquinolines were synthesized and tested in vitro antitumor activity against five human tumor cell lines. The results showed a broad antitumor spectrum for a series of 3-arylisoquinol...
Bailey, S Bolognese, B Buckle, D R Faller, A Jackson, S Louis-Flamberg, P McCord, M Mayer, R J Marshall, L A Smith, D G
...
Published in
Bioorganic & medicinal chemistry letters
A series of hydroxamic acids related to the non-selective matrix metalloproteinase inhibitor Batimastat has been prepared, some members of which are potent inhibitors of the processing of the low affinity IgE receptor (CD 23). Increased activity is obtained by appropriate substitution at the alpha-position, whilst selectivity is gained by use of a ...
Fitzhugh, A L
Published in
Bioorganic & medicinal chemistry letters
Clindamycin's three-dimensional structure is shown via a computer rendered stereomodel to be strikingly similar to L-Pro-Met and the D-ribosyl ring of adenosine. This discovery has important implications for the rational design of new licosamides and for efforts to understand how this and related classes of agents selectively inhibit protein biosyn...
Owens, A P Harrison, T Moseley, J D Swain, C J Sadowski, S Cascieri, M A
Published in
Bioorganic & medicinal chemistry letters
Heterocyclic replacements for the carboxamido group of the previously disclosed phenylglycinol-based human NK1 (hNK1) receptor antagonists have been investigated, ultimately leading to acyclic compounds with sub-nanomolar affinity for the hNK1 receptor.